Abstract: 6/7-Seco rearranged spiro-indolone alkaloids, meloyunines A (1) and B (2) and a monoterpenoid quinoline alkaloid meloyunine C (3) together with its possible intermediate 14,15-dehydromelohenine B (4), and their precursor ∆ 14 -vincamenine (5) were isolated from Melodinus yunnanensis. All structures were elucidated based on NMR, FTIR, UV, and MS spectroscopic data. The isolation of monoterpenoid indole, quinoline, and its immediate from the same plant chemically supported the biosynthesis of quinoline from indole. Compound 2 was cytotoxic against several human cancer cell lines.
Introduction
Monoterpenoid indole alkaloids originate from the condensation of tryptophan with secologanin to produce strictosidine, which further alters by rearrangement to yield a dozen subgroups.
1 Some of the remarkable quinoline alkaloids, such as quinine and camptothecin which are well known for their antimalarial and anticancer properties, respectively, have been proposed to arise by rearrangement of monoterpenoid indole alkaloids. In a possible route for quinine biosynthesis, the cleavage of a N 1 -C 2 bond in the indole heterocyclic ring could generate new amine and keto functions. A new quinoline heterocycle would then be formed by combining this N-1 amine with a C-5 aldehyde produced by a tryptamine sidechain cleavage, producing cinchonidinone.
2 Unlike quinine, the proposed biosynthesis of camptothecin includes a C 2 -C 7 double bond oxidation to yield two carbonyls and an aldoltype condensation between C 2 and C 6 to form a quinoline ring. An in vivo tracer experiment has supported the prediction that the quinoline moiety originates from tryptophan.
3 Also, melodinine B, a possible key intermediate of indole to quinoline alkaloids, has been reported. 4 Plants of the genus Melodinus have been shown to be good sources of monoterpenoid indole and quinoline alkaloids.
5 During our search for novel and bioactive monoterpenoid indole alkaloids from the family Apocynaceae, some representative skeletons and cytotoxic compounds were reported from the genera Alstonia 6 and Melodinus. 4, 7 This paper describes skeletons and cytotoxic compounds were reported from the genera Alstonia 6 and Melodinus. 4, 7 This paper describes the isolation, structural determination, proposed biosynthesis, and cytotoxic activities of 4 novel alkaloids (1-4) from M. yunnanensis.
Results and Discussion
Compound 1 was found to possess a molecular formula of C 19 H 20 N 2 O, as evidenced by high resolution electron spray ionization mass spectra (HRESIMS) at m/z 293.1650, in combination with 1 H, 13 C NMR, DEPT spectra, and appropriate for 11 degrees of unsaturation. The UV spectrum showed the presence of conjugated groups by showing maximum absorptions at 247 and 278 nm, and the IR spectrum indicated the presence of carbonyl and olefin groups (absorption bands at 1702 and 1610 cm -1 , respectively). -8) , and 107.9 (C-7) of 5 were absent in 1, instead δ C 204.0 (s), 73.9 (s), 159.8 (s), and 120.8 (s) were present in 1. In the heteronuclear multiple bond coherence (HMBC) spectrum of 1 (Figure 2 ), the correlation of δ H 7.55 (1H, H-9) with δ C 204.0 (s) suggested an indolone fragment, and the correlation of δ H 6.69 (H-16), 1.88, 2.08 (H-6), and 3.10 (H-5) with δ C 73.9 (s) led to the assignment of C-2 to a conjunct carbon of a spiral ring ( Figure  1 ). Nuclear Overhauser Effect (NOE) correlation between H-21 and H-19 in the ROESY spectrum of 1 indicated three protons on the same side, a α-orientation identical to the configuration of its biosynthetic precursor, ∆
14
-vincamenine. 9 Thus, the C-5 and 6 of the spiral ring (C) were on the upside of the planar indole configuration in a molecular model. Rings A, D, and E of 1 were same as those of 5, as indicated by the HMBC and ROESY spectra.
Compound 2 C NMR spectra were very similar to those of 1, except for δ C 85.5 (d), 36.2 (t), and an additional methoxyl δ C 54.2 (q) in 2 instead of the olefinic signals at C-16/17 in 1. This suggested an added methoxyl group at C-16 in 2, which was further supported by the HMBC spectrum, with correlations of δ H 5.04 (1H, t, J = 8.0 Hz, H-16) with C-2, 13, and 17. In the ROESY spectrum, NOE correlation of δ H 5.04 (H-16) with δ H 0.77 and 0.87 (2H, m, H-19), and of δ H 3.39 (3H, s, OCH 3 ) with 2.19 (2H, m, H-6) placed the methoxyl as β. Other structural parts of 2 were identical to 1, as indicated by the HMBC and ROESY spectra.
Compound 3 The possible biosynthetic relationships of these new compounds in which they were derived from a common precursor 5 was proposed here (Figure 3 ). Different oxidation processes may have produced two kinds of intermediates, from which 4 was isolated. Further rearrangement then formed two new skeletons, including the spiro-indolone alkaloids (1 and 2), and a quinolone alkaloid (3). To our knowledge, this is the first report of the co-occurrence of monoterpenoid indoles (1, 2, and 5), a quinoline (3), and their key intermediates (4) in same plant, supporting the biosynthesis of quinoline from indole and concurring with previous in vivo tracer experiments in the literature.
Compounds 1-5 were evaluated for their cytotoxicity against five human cancer cell lines, MCF-7 breast, SMMC-7721 hepatocellular carcinoma, HL-60 myeloid leukemia, SW480 colon cancer, and A-549 lung cancer. Extraction and Isolation. Dried and powdered leaves and twigs of M. yunnanensis (40 kg) were extracted three times with methanol (MeOH) at room temperature and the solvent evaporated in vacuo. The residue was dissolved in 0.3% aqueous hydrochloric acid, and the solution subsequently basified using ammonia water to pH 9-10. The basic solution was partitioned with EtOAc, producing an aqueous and EtOAc phase. The resulting EtOAc fraction (205 g) was collected and then subjected to column chromatography over silica gel and eluted with a chloroform-acetone gradient (1/0 to 3/1, v/v) to afford five fractions (I-VII), which were concentrated in vacuo. Fraction II (5 g) was further chromatographed using a petroleum ether-acetone gradient (19/1 to 9/1, v/v) as the eluent to yield 8 subfractions, II-1-II-8. Compound 4 (46 mg) was crystallized from II-8 (90 mg). Subfraction II-1 (112 mg) was separated by semi-preparative reversed-phase C 18 -HPLC on a Sunfire column (19 × 250 mm) with a gradient flow of 70-75% aqueous MeOH to yield 2 (5 mg). II-3 (120 mg) was further purified on a same semi-preparative column with a gradient flow of 65-80% aqueous MeOH to afford 5 (107 mg). Similar semi-preparative column separations with gradient Cytotoxicity Assay. Five human cancer cell lines, MCF-7 breast, SMMC-7721 hepatocellular carcinoma, HL-60 myeloid leukemia, SW480 colon cancer, and A-549 lung cancer, were used in the cytotoxic assay. Cells were cultured in RPMI-1640 or in DMEM medium (Hyclone, USA), supplemented with 10% fetal bovine serum (Hyclone, USA) in 5% CO 2 at 37 °C. The cytotoxicity assay was performed according to the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) method in 96-well microplates. 11 Briefly, 100 μL of adherent cells was seeded into each well of 96-well cell culture plates and allowed to adhere for 12 h before addition of test compounds, while suspended cells were seeded just before drug addition with initial density of 1 × 10 5 cells/mL. Each tumor cell line was exposed to the test compound at concentrations of 0.0625, 0.32, 1.6, 8, and 40 μM in triplicates for 48 h, with cisplatin (Sigma, USA) as positive control. After compound treatment, cell viability was detected and a cell growth curve was graphed. IC 50 values were calculated by Reed and Muench's method.
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